- Report
- October 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2025
- 302 Pages
Global
From €3993EUR$4,200USD£3,354GBP
- Report
- August 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- May 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 195 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 189 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- January 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- November 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP

Process Development in biotechnology is the process of designing, optimizing, and validating manufacturing processes for biopharmaceuticals. It involves the development of processes for the production of biopharmaceuticals, such as monoclonal antibodies, recombinant proteins, and vaccines. The process development process includes the development of analytical methods, process characterization, process optimization, and process validation. It also involves the development of process control strategies, such as process monitoring and process control systems.
Process development is a critical step in the development of biopharmaceuticals, as it ensures that the product is safe, effective, and of high quality. It is also important for the efficient and cost-effective production of biopharmaceuticals.
Companies in the Process Development market include Merck, Pfizer, Novartis, Amgen, and Genentech. Show Less Read more